整合素αvβ6 PET显像在肺癌放疗患者中的研究
该研究对放疗后6个月内非小细胞肺癌患者行[18F]-FBA-A20FMDV2 PET扫描,并按放疗剂量分区分析摄取。结果显示受照肺摄取高于健康肺,且摄取与分次剂量和纤维化生物效应剂量呈药效学关系,提示αvβ6参与放射性肺纤维化。
要点
- 受照肺αvβ6 PET摄取高于健康肺(SUV10-60 2.97 vs 1.99,P<.05)。
- 摄取与分次剂量(r2=0.63,P<.001)及纤维化BED呈正相关。
- αvβ6-PET可能有助于评估和管理放射性肺纤维化。
核心结论
- 受照肺摄取增高及与分次剂量和纤维化BED的药效学关系,支持αvβ6在放射性肺纤维化诱导中的作用。
研究设计与样本
- 研究纳入6例放疗后6个月内非小细胞肺癌患者和6名健康志愿者,行[18F]-FBA-A20FMDV2 PET扫描并与放疗计划CT配准。
主要发现
- 受照肺平均PET摄取(SUV10-60)高于健康肺(2.97 vs 1.99;P<.05)。
- 放射性配体摄取与分次剂量呈显著正相关(r2=0.63;P<.001)。
- 摄取与纤维化BED呈正相关(α/β 3 Gy时r2=0.38,P<.001;α/β 5 Gy时r2=0.33,P<.001)。
临床怎么用
- αvβ6-PET显像可能用于评估和管理放射性肺纤维化,但需进一步验证。
局限性
- 样本量小(6例患者和6名健康志愿者),扫描时间为放疗后6至22周。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Post radiation therapy (RT) lung fibrosis is a major barrier to improved cure rate in lung cancer. Integrin αvβ6 plays a key role in fibrogenesis by activating transforming growth factor-β. Positron emission tomography (PET) studies with a fluorine-18 radiolabelled αvβ6 radioligand, [18F]-FBA-A20FMDV2, were performed to assess uptake, and the relationship to RT dose parameters was explored. METHODS AND MATERIALS: Recently treated non-small cell lung cancer patients (<6 months after RT) had [18F]-FBA-A20FMDV2-PET scans, coregistered with the RT planning computed tomography and segmented to RT doses of >40 Gy (excluding tumor), 25 to 40 Gy, 15 to 25 Gy, 8 to 15 Gy, and <8 Gy. PET uptake (standardized uptake value; SUV) corrected for tissue density between 10 and 60 minutes (SUV10-60) was calculated and compared with RT dose, dose per fraction, and biological effective dose (BED). PET uptake was also evaluated in healthy volunteers. RESULTS: Six non-small cell lung cancer (3 male; 3 female) subjects scanned between 6 and 22 weeks after RT and 6 healthy volunteers (3 males; 3 females) were evaluated. Higher mean PET uptake (SUV10-60) was observed in the irradiated lung compared with the healthy lung (2.97 vs 1.99; P < .05). A significant and positive pharmacodynamic relationship was observed between radioligand uptake (SUV10-60) and dose per RT fraction (r2 = 0.63; P < .001) and with BED for fibrosis (r2 = 0.38; P < .001 for α/β 3 Gy and r2 = 0.33; P < 0.001 for α/β 5 Gy). CONCLUSIONS: Higher uptake in the irradiated lung and a pharmacodynamic relationship between αvβ6 radioligand uptake versus RT dose per fraction and BED for lung fibrosis is consistent with RT induced activation of αvβ6 integrin and supports a role for αvβ6 in the induction of lung fibrosis after pulmonary RT. αvβ6-PET imaging may potentially aid in the assessment and management of radiation-induced pulmonary fibrosis.
引用
- Saleem A, Helo Y, Win Z, et al. Integrin αvβ6 Positron Emission Tomography Imaging in Lung Cancer Patients Treated With Pulmonary Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020. PMID: 32060008. doi:10.1016/j.ijrobp.2020.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。